$243.61
0.290.12%
Pre-Market: 4:27 PM EDT
15 minutes delayed
Comments
Loading...
Ecolab
ECLNYSE
want to know what
the Bulls & Bears Say?
Ecolab (NYSE:ECL) Stock, Analyst Ratings, Price Targets, Forecasts
Ecolab Inc has a consensus price target of $228.33 based on the ratings of 24 analysts. The high is $283 issued by Stifel on July 8, 2024. The low is $135 issued by Deutsche Bank on November 2, 2022. The 3 most-recent analyst ratings were released by Citigroup, RBC Capital, and UBS on July 12, 2024, July 11, 2024, and July 9, 2024, respectively. With an average price target of $269.67 between Citigroup, RBC Capital, and UBS, there's an implied 10.70% upside for Ecolab Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
RBC Capital
UBS
Stifel
BMO Capital
1calculated from analyst ratings
Analyst Ratings for Ecolab
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | Buy Now | 9.6% | Citigroup | Patrick Cunningham | $257 → $267 | Maintains | Neutral | Get Alert |
| 07/11/2024 | Buy Now | 6.73% | RBC Capital | Ashish Sabadra | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 07/09/2024 | Buy Now | 15.76% | UBS | Joshua Spector | $270 → $282 | Maintains | Buy | Get Alert |
| 07/08/2024 | Buy Now | 16.17% | Stifel | Shlomo Rosenbaum | $233 → $283 | Upgrade | Hold → Buy | Get Alert |
| 06/20/2024 | Buy Now | 6.73% | RBC Capital | Ashish Sabadra | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 06/04/2024 | Buy Now | 6.73% | RBC Capital | Ashish Sabadra | $260 → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 05/21/2024 | Buy Now | 10.83% | UBS | Joshua Spector | $269 → $270 | Maintains | Buy | Get Alert |
| 05/21/2024 | Buy Now | 6.73% | RBC Capital | Ashish Sabadra | → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 05/01/2024 | Buy Now | 5.5% | Citigroup | Patrick Cunningham | $256 → $257 | Maintains | Neutral | Get Alert |
| 05/01/2024 | Buy Now | 6.73% | RBC Capital | Ashish Sabadra | $238 → $260 | Maintains | Outperform | Get Alert |
| 05/01/2024 | Buy Now | -3.94% | BMO Capital | John McNulty | $227 → $234 | Maintains | Market Perform | Get Alert |
| 05/01/2024 | Buy Now | -7.64% | JP Morgan | Jeffrey Zekauskas | $220 → $225 | Maintains | Neutral | Get Alert |
| 05/01/2024 | Buy Now | -4.36% | Stifel | Shlomo Rosenbaum | $225 → $233 | Maintains | Hold | Get Alert |
| 05/01/2024 | Buy Now | -0.25% | Baird | Andrew Wittmann | $232 → $243 | Maintains | Neutral | Get Alert |
| 04/12/2024 | Buy Now | 6.73% | Mizuho | John Roberts | $216 → $260 | Upgrade | Neutral → Buy | Get Alert |
| 04/10/2024 | Buy Now | 5.09% | Citigroup | Patrick Cunningham | $237 → $256 | Maintains | Neutral | Get Alert |
| 04/09/2024 | Buy Now | -2.3% | RBC Capital | Ashish Sabadra | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 04/03/2024 | Buy Now | 2.62% | Raymond James | Pavel Molchanov | $230 → $250 | Maintains | Outperform | Get Alert |
| 04/03/2024 | Buy Now | 6.73% | Piper Sandler | Charles Neivert | → $260 | Initiates | → Overweight | Get Alert |
| 03/27/2024 | Buy Now | -1.48% | Morgan Stanley | Vincent Andrews | $230 → $240 | Maintains | Equal-Weight | Get Alert |
| 03/12/2024 | Buy Now | -2.3% | RBC Capital | Ashish Sabadra | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
| 02/28/2024 | Buy Now | 6.73% | Barclays | Manav Patnaik | $225 → $260 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/14/2024 | Buy Now | 2.62% | Wells Fargo | Seth Weber | $240 → $250 | Maintains | Overweight | Get Alert |
| 02/14/2024 | Buy Now | -4.77% | Baird | Andrew Wittmann | $184 → $232 | Maintains | Neutral | Get Alert |
| 02/14/2024 | Buy Now | -6.82% | BMO Capital | John McNulty | $212 → $227 | Maintains | Market Perform | Get Alert |
| 02/14/2024 | Buy Now | -2.71% | Citigroup | Patrick Cunningham | $220 → $237 | Maintains | Neutral | Get Alert |
| 02/14/2024 | Buy Now | -2.3% | RBC Capital | Ashish Sabadra | → $238 | Reiterates | Outperform → Outperform | Get Alert |
| 02/14/2024 | Buy Now | -11.33% | Mizuho | John Roberts | $210 → $216 | Maintains | Neutral | Get Alert |
| 02/14/2024 | Buy Now | -7.64% | Barclays | Manav Patnaik | $215 → $225 | Maintains | Equal-Weight | Get Alert |
| 02/14/2024 | Buy Now | -7.64% | Stifel | Shlomo Rosenbaum | $193 → $225 | Maintains | Hold | Get Alert |
| 02/14/2024 | Buy Now | -9.69% | JP Morgan | Jeffrey Zekaukas | $200 → $220 | Downgrade | Overweight → Neutral | Get Alert |
| 01/18/2024 | Buy Now | -2.3% | RBC Capital | Ashish Sabadra | $213 → $238 | Maintains | Outperform | Get Alert |
| 01/16/2024 | Buy Now | -11.33% | B of A Securities | Steve Byrne | $185 → $216 | Upgrade | Underperform → Neutral | Get Alert |
| 01/11/2024 | Buy Now | -6.82% | UBS | Joshua Spector | $211 → $227 | Maintains | Buy | Get Alert |
| 01/08/2024 | Buy Now | — | Seaport Global | Michael Harrison | — | Downgrade | Buy → Neutral | Get Alert |
| 12/14/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 12/06/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 12/05/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 11/30/2023 | Buy Now | -13.8% | Raymond James | Pavel Molchanov | → $210 | Initiates | → Outperform | Get Alert |
| 11/01/2023 | Buy Now | -20.78% | Stifel | Shlomo Rosenbaum | $187 → $193 | Maintains | Hold | Get Alert |
| 10/09/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 10/04/2023 | Buy Now | -23.24% | Citigroup | Patrick Cunningham | $207 → $187 | Maintains | Neutral | Get Alert |
| 09/15/2023 | Buy Now | -20.36% | Mizuho | Christopher Parkinson | → $194 | Reiterates | Neutral → Neutral | Get Alert |
| 09/15/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 09/08/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | Outperform → Outperform | Get Alert |
| 09/01/2023 | Buy Now | -26.11% | Berenberg | Andres Castanos Mollor | → $180 | Initiates | → Hold | Get Alert |
| 08/07/2023 | Buy Now | -19.95% | BMO Capital | John McNulty | $190 → $195 | Maintains | Market Perform | Get Alert |
| 08/02/2023 | Buy Now | -17.9% | JP Morgan | Jeffrey Zekaukas | $186 → $200 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | -23.24% | Stifel | Shlomo Rosenbaum | $172 → $187 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | -22.01% | Morgan Stanley | Vincent Andrews | $175 → $190 | Maintains | Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | -11.74% | Wells Fargo | Seth Weber | $208 → $215 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | -17.9% | Baird | Andrew Wittmann | $174 → $200 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | -20.36% | Mizuho | Christopher Parkinson | $177 → $194 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | -15.03% | Citigroup | Patrick Cunningham | $200 → $207 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | -17.9% | Barclays | Manav Patnaik | $165 → $200 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | Buy Now | -17.9% | Citigroup | Patrick Cunningham | $179 → $200 | Maintains | Neutral | Get Alert |
| 07/05/2023 | Buy Now | -25.7% | B of A Securities | Steve Byrne | $163 → $181 | Maintains | Underperform | Get Alert |
| 07/05/2023 | Buy Now | -14.62% | Wells Fargo | Seth Weber | $195 → $208 | Maintains | Overweight | Get Alert |
| 07/05/2023 | Buy Now | — | Northcoast Research | Ryan Connors | — | Downgrade | Buy → Neutral | Get Alert |
| 06/14/2023 | Buy Now | -26.52% | Citigroup | Patrick Cunningham | → $179 | Initiates | → Neutral | Get Alert |
| 06/01/2023 | Buy Now | -12.57% | RBC Capital | Ashish Sabadra | → $213 | Reiterates | → Outperform | Get Alert |
| 05/16/2023 | Buy Now | -24.06% | RBC Capital | Ashish Sabadra | → $185 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | Buy Now | -22.83% | BMO Capital | John McNulty | $167 → $188 | Maintains | Market Perform | Get Alert |
| 05/04/2023 | Buy Now | -28.16% | Morgan Stanley | Vincent Andrews | $145 → $175 | Maintains | Equal-Weight | Get Alert |
| 05/03/2023 | Buy Now | -19.95% | Wells Fargo | Seth Weber | $175 → $195 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | -27.34% | Mizuho | Christopher Parkinson | $163 → $177 | Maintains | Neutral | Get Alert |
| 04/17/2023 | Buy Now | -33.5% | B of A Securities | Steve Byrne | $170 → $162 | Downgrade | Neutral → Underperform | Get Alert |
| 03/22/2023 | Buy Now | -29.4% | Stifel | Shlomo Rosenbaum | $164 → $172 | Maintains | Hold | Get Alert |
| 02/16/2023 | Buy Now | -31.86% | Citigroup | PJ Juvekar | $164 → $166 | Maintains | Neutral | Get Alert |
| 02/15/2023 | Buy Now | -32.68% | Stifel | Shlomo Rosenbaum | $140 → $164 | Maintains | Hold | Get Alert |
| 02/15/2023 | Buy Now | -28.16% | Wells Fargo | Seth Weber | $168 → $175 | Maintains | Overweight | Get Alert |
| 02/15/2023 | Buy Now | -32.27% | Barclays | Manav Patnaik | $160 → $165 | Maintains | Equal-Weight | Get Alert |
| 02/15/2023 | Buy Now | -24.06% | RBC Capital | Ashish Sabadra | $155 → $185 | Upgrade | Sector Perform → Outperform | Get Alert |
| 01/13/2023 | Buy Now | -31.04% | Wells Fargo | Seth Weber | $160 → $168 | Maintains | Overweight | Get Alert |
| 01/12/2023 | Buy Now | -33.09% | Mizuho | Christopher Parkinson | $158 → $163 | Maintains | Neutral | Get Alert |
| 12/15/2022 | Buy Now | -32.68% | Citigroup | PJ Juvekar | $146 → $164 | Maintains | Neutral | Get Alert |
| 12/02/2022 | Buy Now | -34.32% | Barclays | Manav Patnaik | $170 → $160 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/07/2022 | Buy Now | -40.48% | Morgan Stanley | Vincent Andrews | $181 → $145 | Maintains | Equal-Weight | Get Alert |
| 11/07/2022 | Buy Now | -30.22% | Credit Suisse | John Roberts | $175 → $170 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | -41.3% | BMO Capital | John McNulty | $169 → $143 | Maintains | Market Perform | Get Alert |
| 11/02/2022 | Buy Now | -35.14% | Mizuho | Christopher Parkinson | $178 → $158 | Maintains | Neutral | Get Alert |
| 11/02/2022 | Buy Now | -44.58% | Deutsche Bank | David Begleiter | $165 → $135 | Downgrade | Buy → Hold | Get Alert |
| 10/17/2022 | Buy Now | -32.27% | Deutsche Bank | David Begleiter | $180 → $165 | Maintains | Buy | Get Alert |
| 10/13/2022 | Buy Now | -22.01% | Seaport Global | Michael Harrison | → $190 | Upgrade | Neutral → Buy | Get Alert |
| 09/06/2022 | Buy Now | — | Northcoast Research | Ryan Connors | — | Upgrade | Neutral → Buy | Get Alert |
| 07/27/2022 | Buy Now | -29.81% | Baird | Andrew Wittmann | $193 → $171 | Maintains | Outperform | Get Alert |
| 07/27/2022 | Buy Now | -26.93% | Mizuho | Christopher Parkinson | $183 → $178 | Maintains | Neutral | Get Alert |
| 07/27/2022 | Buy Now | -29.4% | BMO Capital | John McNulty | $181 → $172 | Maintains | Market Perform | Get Alert |
| 07/13/2022 | Buy Now | -24.88% | B of A Securities | Steve Byrne | $193 → $183 | Downgrade | Buy → Neutral | Get Alert |
| 07/13/2022 | Buy Now | -23.24% | Wells Fargo | Seth Weber | → $187 | Initiates | → Overweight | Get Alert |
| 06/29/2022 | Buy Now | -24.88% | Mizuho | Christopher Parkinson | $198 → $183 | Maintains | Neutral | Get Alert |
| 06/27/2022 | Buy Now | -25.7% | Morgan Stanley | Vincent Andrews | $200 → $181 | Maintains | Equal-Weight | Get Alert |
| 06/08/2022 | Buy Now | -19.95% | Deutsche Bank | David Begleiter | $200 → $195 | Maintains | Buy | Get Alert |
| 06/03/2022 | Buy Now | -19.95% | Credit Suisse | John Roberts | $180 → $195 | Upgrade | Neutral → Outperform | Get Alert |
| 06/02/2022 | Buy Now | -15.85% | UBS | Joshua Spector | $186 → $205 | Upgrade | Neutral → Buy | Get Alert |
| 05/31/2022 | Buy Now | -17.9% | Argus Research | David Coleman | $230 → $200 | Maintains | Buy | Get Alert |
| 05/20/2022 | Buy Now | -26.11% | Credit Suisse | John Roberts | $205 → $180 | Assumes | → Neutral | Get Alert |
| 04/27/2022 | Buy Now | -18.72% | Mizuho | Christopher Parkinson | $210 → $198 | Maintains | Neutral | Get Alert |
| 04/27/2022 | Buy Now | -22.01% | JP Morgan | Jeffrey Zekaukas | $191 → $190 | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Ecolab (ECL) stock?
The latest price target for Ecolab (NYSE:ECL) was reported by Citigroup on July 12, 2024. The analyst firm set a price target for $267.00 expecting ECL to rise to within 12 months (a possible 9.60% upside). 57 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Ecolab (ECL)?
The latest analyst rating for Ecolab (NYSE:ECL) was provided by Citigroup, and Ecolab maintained their neutral rating.
When was the last upgrade for Ecolab (ECL)?
The last upgrade for Ecolab Inc happened on July 8, 2024 when Stifel raised their price target to $283. Stifel previously had a hold for Ecolab Inc.
When was the last downgrade for Ecolab (ECL)?
The last downgrade for Ecolab Inc happened on February 14, 2024 when JP Morgan changed their price target from $200 to $220 for Ecolab Inc.
When is the next analyst rating going to be posted or updated for Ecolab (ECL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ecolab, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ecolab was filed on July 12, 2024 so you should expect the next rating to be made available sometime around July 12, 2025.
Is the Analyst Rating Ecolab (ECL) correct?
While ratings are subjective and will change, the latest Ecolab (ECL) rating was a maintained with a price target of $257.00 to $267.00. The current price Ecolab (ECL) is trading at is $243.61, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.